NRX Pharmaceuticals (NRXP) Cash & Equivalents Growth (1y) (2018 - 2026)
NRX Pharmaceuticals (NRXP) Cash & Equivalents Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 23.81% |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | 15.53% |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 90.42% |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 17.50% |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -4.13% |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 71.81% |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | NRX Pharmaceuticals | 117.34 Mn | 110.64 Mn | 437,000.00 | 21.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.82% |
| Dec 31, 2025 | 440.33% |
| Sep 30, 2025 | 349.00% |
| Jun 30, 2025 | 52.63% |
| Mar 31, 2025 | 316.98% |
| Dec 31, 2024 | -68.60% |
| Sep 30, 2024 | -82.03% |
| Jun 30, 2024 | -87.31% |
| Mar 31, 2024 | -92.01% |
| Dec 31, 2023 | -77.09% |
| Sep 30, 2023 | -51.22% |
| Jun 30, 2023 | -39.02% |
| Mar 31, 2023 | -58.94% |
| Dec 31, 2022 | -27.35% |
| Sep 30, 2022 | -53.07% |
| Jun 30, 2022 | 83.38% |
| Mar 31, 2022 | 202.92% |
| Dec 31, 2021 | 1,385.33% |
| Sep 30, 2021 | 2,919.48% |
| Jun 30, 2021 | 1,244.03% |